What is it about?
We demonstrate that there is little difference in outcome with Bivalirudin versus heparin in patients undergoing radial PCI
Featured Image
Why is it important?
Heparin is inexpensive and provides similar benefits
Read the Original
This page is a summary of: The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium, European Heart Journal, September 2015, European Society of Cardiology,
DOI: 10.1093/eurheartj/ehv434.
You can read the full text:
Contributors
The following have contributed to this page
